Cybille Delacroix Muirhei

Array ( [id] => 7367960 [patent_doc_number] => 20040006087 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'Method of treating cancer using FPT inhibitors and antineoplastic agents' [patent_app_type] => new [patent_app_number] => 10/308813 [patent_app_country] => US [patent_app_date] => 2002-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 60574 [patent_no_of_claims] => 91 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1394 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0006/20040006087.pdf [firstpage_image] =>[orig_patent_app_number] => 10308813 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6779219 [patent_doc_number] => 20030050301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-13 [patent_title] => 'Combination of aldose reductase inhibitors and angiotensin-II antagonists for the treatment of diabetic nephropathy' [patent_app_type] => new [patent_app_number] => 10/280388 [patent_app_country] => US [patent_app_date] => 2002-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8939 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0050/20030050301.pdf [firstpage_image] =>[orig_patent_app_number] => 10280388 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 979117 [patent_doc_number] => 06930121 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-08-16 [patent_title] => 'Compounds and methods for use thereof in the treatment of viral infections' [patent_app_type] => utility [patent_app_number] => 10/267051 [patent_app_country] => US [patent_app_date] => 2002-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11782 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/930/06930121.pdf [firstpage_image] =>[orig_patent_app_number] => 10267051 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 612854 [patent_doc_number] => 07148252 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-12-12 [patent_title] => 'Use of benzopyranones for treating or preventing a primary brain cancer or a brain metastasis' [patent_app_type] => utility [patent_app_number] => 10/261198 [patent_app_country] => US [patent_app_date] => 2002-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10621 [patent_no_of_claims] => 78 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/148/07148252.pdf [firstpage_image] =>[orig_patent_app_number] => 10261198 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7622230 [patent_doc_number] => 06977271 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-12-20 [patent_title] => 'Method for inhibition of angiogenesis and vasculogenesis' [patent_app_type] => utility [patent_app_number] => 10/232284 [patent_app_country] => US [patent_app_date] => 2002-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 11 [patent_no_of_words] => 5404 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/977/06977271.pdf [firstpage_image] =>[orig_patent_app_number] => 10232284 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6730735 [patent_doc_number] => 20030186925 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Farnesyl protein transferase inhibitor combinations with anti-tumor nucleoside derivatives' [patent_app_type] => new [patent_app_number] => 10/220395 [patent_app_country] => US [patent_app_date] => 2002-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10259 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20030186925.pdf [firstpage_image] =>[orig_patent_app_number] => 10220395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6660225 [patent_doc_number] => 20030134869 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-17 [patent_title] => 'Novel therapeutic use of nicergoline' [patent_app_type] => new [patent_app_number] => 10/218666 [patent_app_country] => US [patent_app_date] => 2002-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1894 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20030134869.pdf [firstpage_image] =>[orig_patent_app_number] => 10218666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6716491 [patent_doc_number] => 20030027839 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-06 [patent_title] => 'Farnesyl protein transferase inhiitors for treating breast cancer' [patent_app_type] => new [patent_app_number] => 10/203083 [patent_app_country] => US [patent_app_date] => 2002-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10617 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20030027839.pdf [firstpage_image] =>[orig_patent_app_number] => 10203083 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6329167 [patent_doc_number] => 20020198155 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-26 [patent_title] => 'Pharmaceutical combined preparation and its use in the treatment of gynaecological disorders' [patent_app_type] => new [patent_app_number] => 10/207907 [patent_app_country] => US [patent_app_date] => 2002-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2550 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20020198155.pdf [firstpage_image] =>[orig_patent_app_number] => 10207907 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6653593 [patent_doc_number] => 20030008921 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-09 [patent_title] => 'Medicament and therapeutical method for treating idiopathic asthenozoospermia' [patent_app_type] => new [patent_app_number] => 10/195551 [patent_app_country] => US [patent_app_date] => 2002-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1992 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20030008921.pdf [firstpage_image] =>[orig_patent_app_number] => 10195551 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6801698 [patent_doc_number] => 20030096863 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-22 [patent_title] => 'Method for inhibition or treatment of colon tumorigenesis' [patent_app_type] => new [patent_app_number] => 10/195834 [patent_app_country] => US [patent_app_date] => 2002-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4035 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20030096863.pdf [firstpage_image] =>[orig_patent_app_number] => 10195834 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6733033 [patent_doc_number] => 20030010668 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-16 [patent_title] => 'Desiccating container for moisture-sensitive material' [patent_app_type] => new [patent_app_number] => 10/170755 [patent_app_country] => US [patent_app_date] => 2002-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6438 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20030010668.pdf [firstpage_image] =>[orig_patent_app_number] => 10170755 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6755322 [patent_doc_number] => 20030003099 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-02 [patent_title] => 'Immunosuppressive combination and its use in the treatment or prophylaxis of insulin-producing cell graft rejection' [patent_app_type] => new [patent_app_number] => 10/164755 [patent_app_country] => US [patent_app_date] => 2002-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4777 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20030003099.pdf [firstpage_image] =>[orig_patent_app_number] => 10164755 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6783576 [patent_doc_number] => 20030065024 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-03 [patent_title] => 'Emulsion vehicle for poorly soluble drugs' [patent_app_type] => new [patent_app_number] => 10/151066 [patent_app_country] => US [patent_app_date] => 2002-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 17381 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20030065024.pdf [firstpage_image] =>[orig_patent_app_number] => 10151066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 999605 [patent_doc_number] => 06911456 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-06-28 [patent_title] => 'Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions' [patent_app_type] => utility [patent_app_number] => 10/133006 [patent_app_country] => US [patent_app_date] => 2002-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17605 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/911/06911456.pdf [firstpage_image] =>[orig_patent_app_number] => 10133006 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1220765 [patent_doc_number] => 06703365 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-03-09 [patent_title] => 'Glucagon-like insulinotropic peptides, compositions and methods' [patent_app_type] => B2 [patent_app_number] => 10/125255 [patent_app_country] => US [patent_app_date] => 2002-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6766 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 141 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/703/06703365.pdf [firstpage_image] =>[orig_patent_app_number] => 10125255 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1261809 [patent_doc_number] => 06664266 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-12-16 [patent_title] => 'Axon regeneration with PKC inhibitiors' [patent_app_type] => B2 [patent_app_number] => 10/100690 [patent_app_country] => US [patent_app_date] => 2002-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5865 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/664/06664266.pdf [firstpage_image] =>[orig_patent_app_number] => 10100690 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6550513 [patent_doc_number] => 20020138032 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-26 [patent_title] => 'Treating chronic uremic patients undergoing periodical dialysis' [patent_app_type] => new [patent_app_number] => 10/095985 [patent_app_country] => US [patent_app_date] => 2002-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 2633 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20020138032.pdf [firstpage_image] =>[orig_patent_app_number] => 10095985 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1177954 [patent_doc_number] => 06743777 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-06-01 [patent_title] => 'Cyclic peptide antifungal agents and process for preparation thereof' [patent_app_type] => B1 [patent_app_number] => 10/087088 [patent_app_country] => US [patent_app_date] => 2002-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9861 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/743/06743777.pdf [firstpage_image] =>[orig_patent_app_number] => 10087088 [rel_patent_id] =>[rel_patent_doc_number] =>)